Kelly Michael Aaron — SEC Form 4 filings

SEC reporting owner CIK 1769668. 16 Form 4 filings on record with FilingPulse; latest filed 2026-06-08.

Transaction summary — filings shown

Covers all 16 filings on record, filed 2024-05-15 to 2026-06-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
NEOGENOMICS INC (NEO)Director51 leg · 5,000 sh · $38,00012
Prime Medicine, Inc. (PRME)Director411
AMICUS THERAPEUTICS, INC. (FOLD)Director310
DMC Global Inc. (BOOM)Director44

Form 4 filings — Kelly Michael Aaron

FiledFormIssuerReported transactionsSource
2026-06-084Prime Medicine, Inc. (PRME)Grant/award (A): 75,000 (derivative) @ $0EDGAR
2026-06-034NEOGENOMICS INC (NEO)Option exercise (M): 23,077 @ $0 · Option exercise (M): 23,077 (derivative) @ $0 · Grant/award (A): 11,069 (derivative) @ $0 · Grant/award (A): 15,970 (derivative) @ $0EDGAR
2026-05-144DMC Global Inc. (BOOM)Grant/award (A): 16,937 @ $0EDGAR
2026-04-274AMICUS THERAPEUTICS, INC. (FOLD)Disposition to issuer (D): 72,468 @ $14.50 · Disposition to issuer (D): 36,111 (derivative) · Disposition to issuer (D): 45,423 (derivative) · Disposition to issuer (D): 30,474 (derivative) · Disposition to issuer (D): 42,467 (derivative) · Disposition to issuer (D): 74,872 (derivative)EDGAR
2025-08-054Prime Medicine, Inc. (PRME)Disposition to issuer (D): 13,510 (derivative) · Grant/award (A): 13,510 (derivative) · Disposition to issuer (D): 9,006 (derivative) · Grant/award (A): 9,006 (derivative) · Disposition to issuer (D): 39,062 (derivative) · Grant/award (A): 39,062 (derivative) · +2 moreEDGAR
2025-06-064AMICUS THERAPEUTICS, INC. (FOLD)Grant/award (A): 20,414 @ $0 · Grant/award (A): 74,872 (derivative) @ $0EDGAR
2025-06-054Prime Medicine, Inc. (PRME)Grant/award (A): 55,000 (derivative) @ $0EDGAR
2025-06-034NEOGENOMICS INC (NEO)Option exercise (M): 12,254 @ $0 · Option exercise (M): 12,254 (derivative) @ $0 · Grant/award (A): 16,107 (derivative) @ $0 · Grant/award (A): 23,077 (derivative) @ $0EDGAR
2025-05-284NEOGENOMICS INC (NEO)Purchase (P): 5,000 @ $7.60EDGAR
2025-05-154DMC Global Inc. (BOOM)Grant/award (A): 17,580 @ $0EDGAR
2025-02-274DMC Global Inc. (BOOM)Grant/award (A): 5,518 @ $0EDGAR
2024-08-134NEOGENOMICS INC (NEO)Option exercise (M): 11,336 @ $0 · Option exercise (M): 11,336 (derivative) @ $0EDGAR
2024-06-144Prime Medicine, Inc. (PRME)Grant/award (A): 45,000 (derivative) @ $0EDGAR
2024-06-074AMICUS THERAPEUTICS, INC. (FOLD)Grant/award (A): 11,847 @ $0 · Grant/award (A): 42,467 (derivative) @ $0EDGAR
2024-06-044NEOGENOMICS INC (NEO)Grant/award (A): 8,672 (derivative) @ $0 · Grant/award (A): 12,254 (derivative) @ $0EDGAR
2024-05-154DMC Global Inc. (BOOM)Grant/award (A): 9,520 @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1769668 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →